New diabetes clinical trial: Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease
Published on: 2026-05-05T04:00:00Z Conditions : Obesity Type 2 Diabetes Mellitus; Cardiovascular-kidney-metabolic Syndrome; Metabolic Dysfunction-Associated Steatotic Liver Disease Sponsors : Chung Shan Medical University; National Science and Technology Council, Taiwan Not yet recruiting https://ift.tt/DlANxr7